Crescent Capital BDC (CCAP) Expected to Announce Earnings on Wednesday

Crescent Capital BDC (NASDAQ:CCAP) is expected to be issuing its Q1 2026 results after the market closes on Wednesday, May 13th. Analysts expect the company to announce earnings of $0.41 per share and revenue of $39.5750 million for the quarter. Parties may visit the the company’s upcoming Q1 2026 earning results page for the latest details on the call scheduled for Thursday, May 14, 2026 at 12:00 PM ET.

Crescent Capital BDC (NASDAQ:CCAP) last released its quarterly earnings results on Wednesday, February 25th. The company reported $0.45 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.44 by $0.01. The business had revenue of $19.05 million during the quarter, compared to the consensus estimate of $39.83 million. Crescent Capital BDC had a return on equity of 9.32% and a net margin of 20.64%. On average, analysts expect Crescent Capital BDC to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Crescent Capital BDC Price Performance

CCAP stock opened at $13.92 on Wednesday. The company has a market capitalization of $514.62 million, a P/E ratio of 14.81 and a beta of 0.59. The company has a debt-to-equity ratio of 1.24, a quick ratio of 1.22 and a current ratio of 1.22. Crescent Capital BDC has a 52-week low of $11.80 and a 52-week high of $17.02. The business has a 50-day simple moving average of $12.96 and a two-hundred day simple moving average of $13.82.

Crescent Capital BDC Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, April 15th. Shareholders of record on Tuesday, March 31st were paid a dividend of $0.42 per share. The ex-dividend date was Tuesday, March 31st. This represents a $1.68 dividend on an annualized basis and a yield of 12.1%. Crescent Capital BDC’s payout ratio is 178.72%.

Wall Street Analyst Weigh In

CCAP has been the subject of a number of analyst reports. Wall Street Zen upgraded Crescent Capital BDC from a “sell” rating to a “hold” rating in a research note on Saturday, January 10th. Zacks Research upgraded Crescent Capital BDC from a “strong sell” rating to a “hold” rating in a research note on Tuesday, February 10th. Wells Fargo & Company cut their price target on Crescent Capital BDC from $14.00 to $13.00 and set an “equal weight” rating for the company in a research note on Friday, February 27th. B. Riley Financial initiated coverage on Crescent Capital BDC in a research note on Monday, March 30th. They set a “neutral” rating and a $13.50 price target for the company. Finally, Keefe, Bruyette & Woods cut their price target on Crescent Capital BDC from $15.50 to $15.00 and set an “outperform” rating for the company in a research note on Thursday, April 16th. One analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $15.50.

Hedge Funds Weigh In On Crescent Capital BDC

Institutional investors have recently modified their holdings of the business. Northwestern Mutual Wealth Management Co. bought a new position in shares of Crescent Capital BDC in the fourth quarter valued at approximately $27,000. VPR Management LLC grew its holdings in shares of Crescent Capital BDC by 150.0% in the third quarter. VPR Management LLC now owns 5,000 shares of the company’s stock valued at $71,000 after acquiring an additional 3,000 shares in the last quarter. Permanens Capital L.P. bought a new position in shares of Crescent Capital BDC in the third quarter valued at approximately $147,000. XTX Topco Ltd bought a new position in shares of Crescent Capital BDC in the second quarter valued at approximately $165,000. Finally, NewEdge Advisors LLC grew its holdings in shares of Crescent Capital BDC by 20.2% in the fourth quarter. NewEdge Advisors LLC now owns 12,279 shares of the company’s stock valued at $173,000 after acquiring an additional 2,066 shares in the last quarter. 49.46% of the stock is owned by institutional investors.

About Crescent Capital BDC

Crescent Capital BDC, Inc is a closed-end, externally managed business development company that provides flexible financing solutions to middle market companies in the United States. Trading on the Nasdaq under the ticker CCAP, the firm offers investors exposure to a diversified portfolio of debt and equity instruments, targeting businesses with attractive risk-adjusted return profiles. Its primary objective is to generate current income through interest payments and potential capital appreciation via selective equity co-investments.

The company’s investment strategy emphasizes senior secured loans, unsecured second-lien loans, mezzanine debt, as well as preferred and common equity co-investments.